Clinical trial
Study for Evaluating Different Methods of Measuring Depression Treatment…
NCT00406952 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00406952 |
|---|---|
| Title | Study for Evaluating Different Methods of Measuring Depression Treatment Response |
| Official title | A Phase 4 Randomized, Double-Blind, Placebo Controlled Methodology Study to Evaluate the Time of Onset of AntiDepressant Response in Subjects With Major Depressive Disorder |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug, Procedure |
| Interventions | electronic diary, Sertraline, Placebo, voice acoustics |
| Enrollment | 165 |
| Start date | Nov 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Aug 21, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: